HealthEquity, Inc. $HQY Stake Boosted by DAVENPORT & Co LLC

DAVENPORT & Co LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 23.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 386,388 shares of the company’s stock after acquiring an additional 74,431 shares during the quarter. DAVENPORT & Co LLC’s holdings in HealthEquity were worth $36,773,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of HQY. Westfield Capital Management Co. LP grew its stake in HealthEquity by 124.6% in the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after purchasing an additional 701,819 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of HealthEquity by 1.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company’s stock valued at $100,138,000 after buying an additional 15,458 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of HealthEquity by 2.6% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 1,129,115 shares of the company’s stock valued at $118,286,000 after buying an additional 28,145 shares in the last quarter. Geneva Capital Management LLC increased its holdings in HealthEquity by 6.2% in the second quarter. Geneva Capital Management LLC now owns 1,108,241 shares of the company’s stock worth $116,099,000 after buying an additional 64,487 shares during the last quarter. Finally, AQR Capital Management LLC raised its position in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In other news, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This trade represents a 3.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,240 shares of company stock valued at $1,640,164 in the last 90 days. 1.50% of the stock is currently owned by insiders.

HealthEquity Stock Performance

Shares of HQY opened at $92.69 on Wednesday. The company has a market capitalization of $7.92 billion, a PE ratio of 42.52, a price-to-earnings-growth ratio of 1.36 and a beta of 0.18. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company’s fifty day moving average price is $97.21 and its 200 day moving average price is $96.05.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same period last year, the business posted $0.78 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Jefferies Financial Group boosted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Barrington Research reissued an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. JPMorgan Chase & Co. raised their target price on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $120.00 price target on shares of HealthEquity in a research note on Friday, December 5th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $120.27.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.